From varices to venous ulceration: the story of chronic venous disease described by metalloproteinases

International Wound Journal

Volumn 14, Issue 1, 2017, Pages 233-240

  Serra, Raffaele ^a   Gallelli, Luca ^a   Butrico, Lucia ^a   Buffone, Gianluca ^a,b   Caliò, Francesco G ^b   De Caridi, Giovanni ^c   Massara, Mafalda ^c   Barbetta, Andrea ^a   Amato, Bruno ^a,d   Labonia, Miriam ^a   Mimmi, Selena ^a   Iaccino, Enrico ^a   de Franciscis, Stefano ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b Sant'Anna Hospital   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Chronic venous disease; Metalloproteinases; Skin changes; Varicose veins; Venous ulcer

Indexed keywords

ADAM10 ENDOPEPTIDASE; ADAM12 PROTEIN; ADAMTS1 PROTEIN; ADAMTS7 PROTEIN; AGGRECANASE 1; AGGRECANASE 2; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; METALLOPROTEINASE; NEUTROPHIL COLLAGENASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; MATRIX METALLOPROTEINASE;

ADULT; AGED; ARTICLE; CHRONIC VENOUS DISEASE; CONTROLLED STUDY; CORONA PHLEBECTATICA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SKIN DISEASE; ULCER; VARICOSIS; VEIN DISEASE; BLOOD; CHRONIC DISEASE; CLINICAL TRIAL; ITALY; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; VERY ELDERLY; WOUND HEALING;

ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; ITALY; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; VARICOSE ULCER; WOUND HEALING;

EID: 84962618161     PISSN: 17424801     EISSN: 1742481X     Source Type: Journal    
DOI: 10.1111/iwj.12594     Document Type: Article

References (41)

1. Serra R, Grande R, Butrico L, Fugetto F, de Franciscis S. Epidemiology, diagnosis and treatment of chronic venous disease: a systematic review. Chirurgia 2016;29.
2. Serra R, Buffone G, de Franciscis A, Mastrangelo D, Molinari V, Montemurro R, de Franciscis S. A genetic study of chronic venous insufficiency. Ann Vasc Surg 2012;26:636–642.
3. Eklöf B, Rutherford RB, Bergan JJ, Carpentier PH, Gloviczki P, Kistner RL, Meissner MH, Moneta GL, Myers K, Padberg FT, Perrin M, Ruckley CV, Smith PC, Wakefield TW, American Venous Forum International Ad Hoc Committee for Revision of the CEAP Classification. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg 2004;40:1248–1252.
4. Uhl JF, Cornu-Thénard A, Carpentier PH, Widmer MT, Partsch H, Antignani PL. Clinical and hemodynamic significance of corona phlebectatica in chronic venous disorders. J Vasc Surg 2005;42:1163–1168.
5. Uhl JF, Cornu-Thenard A, Satger B, Carpentier PH. Clinical analysis of the corona phlebectatica. J Vasc Surg 2012;55:150–153.
6. Serra R, Buffone G, Costanzo G, Montemurro R, Scarcello E, Stillitano DM, Damiano R, de Franciscis S. Altered metalloproteinase-9 expression as the least common denominator between varicocele, inguinal hernia and chronic venous disorders. Ann Vasc Surg 2014;28:705–709.
7. de Franciscis S, Serra R. Matrix metalloproteinases and endothelial dysfunction: the search for new prognostic markers and for new therapeutic targets for vascular wall imbalance. Thromb Res 2015;136:5–6.
8. de Franciscis S, Butrico L, Settimio UF, Grande R, Serra R. The endothelial dysfunction in chronic venous disease: a systematic review. Acta Phlebol 2015;16:69–76.
9. Mannello F, Raffetto JD. Matrix metalloproteinase activity and glycosaminoglycans in chronic venous disease: the linkage among cell biology, pathology and translational research. Am J Transl Res 2011;3:149–158.
10. Raffetto JD, Barros YV, Wells AK, Khalil RA. MMP-2 induced vein relaxation via inhibition of [Ca2+]e-dependent mechanisms of venous smooth muscle contraction. Role of RGD peptides. J Surg Res 2010;159:755–764.
11. Kucukguven A, Khalil RA. Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins. Curr Drug Targets 2013;14:287–324.
12. Serra R, Buffone G, Falcone D, Molinari V, Scaramuzzino M, Gallelli L, de Franciscis S. Chronic venous leg ulcers are associated with high levels of metalloproteinases-9 and neutrophil gelatinase-associated lipocalin. Wound Repair Regen 2013;21:395–401.
13. Amato B, Coretti G, Compagna R, Amato M, Buffone G, Gigliotti D, Grande R, Serra R, de Franciscis S. Role of matrix metalloproteinases in non-healing venous ulcers. Int Wound J 2015;12:641–645.
14. Serra R, Grande R, Buffone G, Molinari V, Perri P, Perri A, Amato B, Colosimo M, de Franciscis S. Extracellular matrix assessment of infected chronic venous leg ulcers: role of metalloproteinases and inflammatory cytokines. Int Wound J 2016;13:53–58.
15. Edwards DR, Handsley MM, Pennington CJ. The ADAM metalloproteinases. Mol Aspects Med 2008;29:258–289.
16. Kelwick R, Desanlis I, Wheeler GN, Edwards DR. The ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) family. Genome Biol 2015;16:113.
17. Sansilvestri-Morel P, Rupin A, Jaisson S, Fabiani JN, Verbeuren TJ, Vanhoutte PM. Synthesis of collagen is dysregulated in cultured fibroblasts derived from skin of subjects with varicose veins as it is in venous smooth muscle cells. Circulation 2002;106:479–483.
18. Sansilvestri-Morel P, Fioretti F, Rupin A, Senni K, Fabiani JN, Godeau G, Verbeuren TJ. Comparison of extracellular matrix in skin and saphenous veins from patients with varicose veins: does the skin reflect venous matrix changes? Clin Sci (Lond) 2007;112:229–239.
19. Serra R, Grande R, Buffone G, Costanzo G, Damiano R, De Franciscis S. Chronic venous disease is more aggressive in patients with varicocele. Acta Phlebol 2013;14:57–60.
20. Serra R, Buffone G, Costanzo G, Montemurro R, Perri P, Damiano R, de Franciscis S. Varicocele in younger as risk factor for inguinal hernia and for chronic venous disease in older: preliminary results of a prospective cohort study. Ann Vasc Surg 2013;27:329–331.
21. Jacob MP. Extracellular matrix remodeling and matrix metalloproteinases in the vascular wall during aging and in pathological conditions. Biomed Pharmacother 2003;57:195–202.
22. Dalton SJ, Mitchell DC, Whiting CV, Tarlton JF. Abnormal extracellular matrix metabolism in chronically ischemic skin: a mechanism for dermal failure in leg ulcers. J Invest Dermatol 2005;125:373–379.
23. Stamenkovic I. Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol 2003;200:448–464.
24. Hu J, Van den Steen PE, Sang QX, Opdenakker G. Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases. Nat Rev Drug Discov 2007;6:480–498.
25. Newby AC. Matrix metalloproteinase inhibition therapy for vascular diseases. Vascul Pharmacol 2012;56:232–244.
26. de Franciscis S, Gallelli L, Amato B, Butrico L, Rossi A, Buffone G, Caliò FG, De Caridi G, Grande R, Serra R. Plasma MMP and TIMP evaluation in patients with deep venous thrombosis: could they have a predictive role in the development of post-thrombotic syndrome? Int Wound J in press. DOI: 10.1111/iwj.12489.
27. Serra R, Grande R, Montemurro R, Butrico L, Caliò FG, Mastrangelo D, Scarcello E, Gallelli L, Buffone G, de Franciscis S. The role of matrix metalloproteinases and neutrophil gelatinase-associated lipocalin in central and peripheral arterial aneurysms. Surgery 2015;157:155–162.
28. Busceti MT, Grande R, Amato B, Gasbarro V, Buffone G, Amato M, Gallelli L, Serra R, de Franciscis S. Pulmonary embolism, metalloproteinases and neutrophil gelatinase associated lipocalin. Acta Phlebol 2013;14:115–121.
29. Zhang P, Shen M, Fernandez-Patron C, Kassiri Z. ADAMs family and relatives in cardiovascular physiology and pathology. J Mol Cell Cardiol 2015. DOI: 10.1016/j.yjmcc.2015.10.031.
30. Smiljanic K, Dobutovic B, Obradovic M, Nikolic D, Marche P, Isenovic ER. Involvement of the ADAM 12 in thrombin-induced rat's VSMCs proliferation. Curr Med Chem 2011;18:3382–3386.
31. Nyren-Erickson EK, Jones JM, Srivastava DK, Mallik S. A disintegrin and metalloproteinase-12 (ADAM12): function, roles in disease progression, and clinical implications. Biochim Biophys Acta 2013;1830:4445–4455.
32. Wight TN. The ADAMTS The ADAMTS proteases, extracellular matrix, and vascular disease: waking the sleeping giant(s)!. Arterioscler Thromb Vasc Biol 2005;25:12–14.
33. Jönsson-Rylander AC, Nilsson T, Fritsche-Danielson R, Hammarström A, Behrendt M, Andersson JO, Lindgren K, Andersson AK, Wallbrandt P, Rosengren B, Brodin P, Thelin A, Westin A, Hurt-Camejo E, Lee-Søgaard CH. Role of ADAMTS-1 in atherosclerosis: remodeling of carotid artery, immunohistochemistry, and proteolysis of versican. Arterioscler Thromb Vasc Biol 2005;25:180–185.
34. Ren P, Zhang L, Xu G, Palmero LC, Albini PT, Coselli JS, Shen YH, LeMaire SA. ADAMTS-1 and ADAMTS-4 levels are elevated in thoracic aortic aneurysms and dissections. Ann Thorac Surg 2013;95:570–577.
35. Didangelos A, Mayr U, Monaco C, Mayr M. Novel role of ADAMTS-5 protein in proteoglycan turnover and lipoprotein retention in atherosclerosis. J Biol Chem 2012;287:19341–19345.
36. Zhang L, Yu F, Wang L, Zheng J, Du Y, Huang Y, Liu B, Wang X, Kong W. ADAMTS-7 promotes vascular smooth muscle cells proliferation in vitro and in vivo. Sci China Life Sci 2015;58:674–681.
37. Kessler T, Zhang L, Liu Z, Yin X, Huang Y, Wang Y, Fu Y, Mayr M, Ge Q, Xu Q, Zhu Y, Wang X, Schmidt K, de Wit C, Erdmann J, Schunkert H, Aherrahrou Z, Kong W. ADAMTS-7 inhibits re-endothelialization of injured arteries and promotes vascular remodeling through cleavage of thrombospondin-1. Circulation 2015;131:1191–1201.
38. Wang L, Wang X, Kong W. ADAMTS-7, a novel proteolytic culprit in vascular remodeling. Sheng Li Xue Bao 2010;62:285–294.
39. Arpino V, Brock M, Gill SE. The role of TIMPs in regulation of extracellular matrix proteolysis. Matrix Biol 2015;44–46:247–254.
40. Rabkin SW. Differential expression of MMP-2, MMP-9 and TIMP proteins in thoracic aortic aneurysm – comparison with and without bicuspid aortic valve: a meta-analysis. Vasa 2014;43:433–442.
41. de Franciscis S, Fregola S, Gallo A, Argirò G, Barbetta A, Buffone G, Caliò FG, De Caridi G, Amato B, Serra R. PredyCLU: a prediction system for chronic leg ulcers based on fuzzy logic; part I – exploring the venous side. Int Wound J in press. DOI: 10.1111/iwj.12529.